[Federal Register Volume 84, Number 219 (Wednesday, November 13, 2019)]
[Notices]
[Page 61635]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24649]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention's (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via in person and web conference on December 
3rd, 2019, from 9:30 a.m. EST to 4:30 p.m. EST, and December 4th, 2019, 
from 9:00 a.m. EST to 4:00 p.m. EST.
    The board will meet in open-session in-person on December 3rd, 
2019, from 9:30 a.m. EST to 4:30 p.m. EST to discuss the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs (urine and oral 
fluid specimens) with updates from the Department of Transportation, 
Nuclear Regulatory Commission, and the Department of Defense. Other 
discussion topics include the impact of cannabis laws on drug testing 
and standard variables. There will be additional presentations from the 
Division of Workplace Programs' staff on urine, oral fluid, hair 
Mandatory Guidelines; and the electronic chain of custody. The board 
will meet in closed-session in-person on December 4th, 2019, from 9:00 
a.m. EST to 4:00 p.m. EST to discuss confidential issues surrounding 
the proposed Mandatory Guidelines for Federal Workplace Drug Testing 
Programs (hair), HHS drug panel review, preliminary and unpublished 
studies from the Johns Hopkins University Behavioral Pharmacology 
Research Unit (BPRU); recommendations to the Assistant Secretary for 
Mental Health and Substance Use regarding additional drugs (fentanyl 
and methadone) that may be tested for in the future, and lastly, 
program financials. Therefore, the December 4th, 2019, from 9:00 a.m. 
EST to 4:00 p.m. EST, meeting is closed to the public, as determined by 
the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in 
accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, 
Section 10(d).
    Meeting registration information can be completed at http://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Designated Federal 
Officer, Jennifer Fan.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: December 3, 2019, from 9:30 a.m. to 4:30 p.m. EST: 
OPEN. December 4, 2019, from 9:00 a.m. to 4:00 p.m. EST: CLOSED.
    Place: Substance Abuse and Mental Health Services Administration, 
5th Floor Pavilion A, B, 5600 Fishers Lane, Rockville, MD 20857.
    Contact: Jennifer Fan, Senior Pharmacist, Center for Substance 
Abuse Prevention, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 
20857, Telephone: (240) 276-1759, email: [email protected].

Anastasia Marie Donovan,
Policy Anayst.
[FR Doc. 2019-24649 Filed 11-12-19; 8:45 am]
BILLING CODE 4162-20-P